DekaBank Deutsche Girozentrale
LRMR icon

DekaBank Deutsche Girozentrale’s Larimar Therapeutics LRMR Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,000
Closed -$76K – 1024
2016
Q1 		$76K Sell
1,000
-133
-12% -$10.5K ﹤0.01% 998
2015
Q4 		$86K Buy
1,133
+8
+0.7% +$1.28K ﹤0.01% 980
2015
Q3 		$431K Buy
1,125
+67
+6% +$30.2K 0.01% 722
2015
Q2 		$440K Buy
1,058
+33
+3% +$13.8K 0.01% 727
2015
Q1 		$487K Buy
+1,025
New +$487K 0.01% 722

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

DekaBank Deutsche Girozentrale's LRMR Position: Q2 2016 in Review

DekaBank Deutsche Girozentrale sold out of Larimar Therapeutics (LRMR) in Q2 2016, closing a stake of 1,000 shares — an estimated $76K sold.

DekaBank Deutsche Girozentrale first reported a position in LRMR in Q1 2015 and held it in 5 quarters. The position peaked at $487K in Q1 2015. 73 funds tracked by Wall St. Rank hold LRMR as of Q2 2016.

  • DekaBank Deutsche Girozentrale reported no remaining Larimar Therapeutics position as of Q2 2016 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 1,000 Larimar Therapeutics shares in Q2 2016, an estimated $76K.
  • DekaBank Deutsche Girozentrale first reported a position in Larimar Therapeutics in Q1 2015 and held it in 5 quarters.
  • DekaBank Deutsche Girozentrale's Larimar Therapeutics position peaked at $487K in Q1 2015.
  • 73 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2016, filed 4 Aug 2016.